Phibro Animal HealthNASDAQ: PAHC

Phibro successfully acquires Zoetis Inc.'s MFA portfolio and certain water-soluble products.

The stocks we learn to search for today are top-ranked momentum stocks that might be worth buying to close out October and throughout the last two months of 2024.

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Insulet (PODD). But which of these two stocks is more attractive to value investors?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Phibro Animal Health is focusing on new developments, incremental registrations and volumes of existing vaccine technologies.

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?

PAHC Animal Health business, supported by the flourishing vaccine product line, drives optimism for future growth. However, macroeconomic impacts are a concern.